Logo image of 1LLY.MI

ELI LILLY & CO (1LLY.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:1LLY - US5324571083 - Common Stock

890.3 EUR
-28.4 (-3.09%)
Last: 1/19/2026, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to 1LLY. 1LLY was compared to 54 industry peers in the Pharmaceuticals industry. 1LLY scores excellent on profitability, but there are some minor concerns on its financial health. 1LLY shows excellent growth, but is valued quite expensive already. This makes 1LLY very considerable for growth investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • 1LLY had positive earnings in the past year.
  • 1LLY had a positive operating cash flow in the past year.
  • 1LLY had positive earnings in each of the past 5 years.
  • 1LLY had a positive operating cash flow in each of the past 5 years.
1LLY.MI Yearly Net Income VS EBIT VS OCF VS FCF1LLY.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

  • The Return On Assets of 1LLY (16.02%) is better than 90.74% of its industry peers.
  • The Return On Equity of 1LLY (77.38%) is better than 98.15% of its industry peers.
  • 1LLY has a Return On Invested Capital of 28.84%. This is amongst the best in the industry. 1LLY outperforms 96.30% of its industry peers.
  • 1LLY had an Average Return On Invested Capital over the past 3 years of 21.71%. This is significantly above the industry average of 13.93%.
  • The last Return On Invested Capital (28.84%) for 1LLY is above the 3 year average (21.71%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROIC 28.84%
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1LLY.MI Yearly ROA, ROE, ROIC1LLY.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

  • 1LLY has a Profit Margin of 30.99%. This is amongst the best in the industry. 1LLY outperforms 98.15% of its industry peers.
  • In the last couple of years the Profit Margin of 1LLY has declined.
  • 1LLY has a better Operating Margin (44.41%) than 98.15% of its industry peers.
  • In the last couple of years the Operating Margin of 1LLY has grown nicely.
  • 1LLY's Gross Margin of 83.03% is amongst the best of the industry. 1LLY outperforms 88.89% of its industry peers.
  • 1LLY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
1LLY.MI Yearly Profit, Operating, Gross Margins1LLY.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1LLY is creating value.
  • The number of shares outstanding for 1LLY remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for 1LLY has been reduced compared to 5 years ago.
  • Compared to 1 year ago, 1LLY has a worse debt to assets ratio.
1LLY.MI Yearly Shares Outstanding1LLY.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1LLY.MI Yearly Total Debt VS Total Assets1LLY.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 8.28 indicates that 1LLY is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of 1LLY (8.28) is better than 90.74% of its industry peers.
  • 1LLY has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as 1LLY would need 6.60 years to pay back of all of its debts.
  • 1LLY has a Debt to FCF ratio (6.60) which is comparable to the rest of the industry.
  • 1LLY has a Debt/Equity ratio of 1.72. This is a high value indicating a heavy dependency on external financing.
  • 1LLY has a worse Debt to Equity ratio (1.72) than 75.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Altman-Z 8.28
ROIC/WACC3.1
WACC9.31%
1LLY.MI Yearly LT Debt VS Equity VS FCF1LLY.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • 1LLY has a Current Ratio of 1.55. This is a normal value and indicates that 1LLY is financially healthy and should not expect problems in meeting its short term obligations.
  • 1LLY's Current ratio of 1.55 is fine compared to the rest of the industry. 1LLY outperforms 64.81% of its industry peers.
  • A Quick Ratio of 1.24 indicates that 1LLY should not have too much problems paying its short term obligations.
  • 1LLY has a Quick ratio of 1.24. This is in the better half of the industry: 1LLY outperforms 74.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.24
1LLY.MI Yearly Current Assets VS Current Liabilites1LLY.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 116.22% over the past year.
  • 1LLY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.57% yearly.
  • The Revenue has grown by 45.41% in the past year. This is a very strong growth!
  • 1LLY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.08% yearly.
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%

3.2 Future

  • Based on estimates for the next years, 1LLY will show a very strong growth in Earnings Per Share. The EPS will grow by 32.61% on average per year.
  • Based on estimates for the next years, 1LLY will show a quite strong growth in Revenue. The Revenue will grow by 19.64% on average per year.
EPS Next Y84.97%
EPS Next 2Y58.86%
EPS Next 3Y46.26%
EPS Next 5Y32.61%
Revenue Next Year41.38%
Revenue Next 2Y31.06%
Revenue Next 3Y26.04%
Revenue Next 5Y19.64%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1LLY.MI Yearly Revenue VS Estimates1LLY.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B
1LLY.MI Yearly EPS VS Estimates1LLY.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

3

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 47.53, 1LLY can be considered very expensive at the moment.
  • 1LLY's Price/Earnings ratio is a bit more expensive when compared to the industry. 1LLY is more expensive than 64.81% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.32. 1LLY is valued rather expensively when compared to this.
  • The Price/Forward Earnings ratio is 31.86, which means the current valuation is very expensive for 1LLY.
  • 1LLY's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 1LLY is more expensive than 66.67% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.30, 1LLY is valued a bit more expensive.
Industry RankSector Rank
PE 47.53
Fwd PE 31.86
1LLY.MI Price Earnings VS Forward Price Earnings1LLY.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1LLY is valued a bit more expensive than the industry average as 72.22% of the companies are valued more cheaply.
  • 1LLY's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. 1LLY is more expensive than 62.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF 153.51
EV/EBITDA 36.08
1LLY.MI Per share data1LLY.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • 1LLY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1LLY has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1LLY's earnings are expected to grow with 46.26% in the coming years.
PEG (NY)0.56
PEG (5Y)2.87
EPS Next 2Y58.86%
EPS Next 3Y46.26%

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.67%, 1LLY is not a good candidate for dividend investing.
  • 1LLY's Dividend Yield is comparable with the industry average which is at 1.59.
  • With a Dividend Yield of 0.67, 1LLY pays less dividend than the S&P500 average, which is at 1.86.
Industry RankSector Rank
Dividend Yield 0.67%

5.2 History

  • The dividend of 1LLY is nicely growing with an annual growth rate of 15.59%!
Dividend Growth(5Y)15.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 28.28% of the earnings are spent on dividend by 1LLY. This is a low number and sustainable payout ratio.
  • The dividend of 1LLY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP28.28%
EPS Next 2Y58.86%
EPS Next 3Y46.26%
1LLY.MI Yearly Income VS Free CF VS Dividend1LLY.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B 10B
1LLY.MI Dividend Payout.1LLY.MI Dividend Payout, showing the Payout Ratio.1LLY.MI Dividend Payout.PayoutRetained Earnings

ELI LILLY & CO

BIT:1LLY (1/19/2026, 7:00:00 PM)

890.3

-28.4 (-3.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30
Earnings (Next)02-04
Inst Owners83.09%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap841.67B
Revenue(TTM)59.42B
Net Income(TTM)18.41B
Analysts81.08
Price Target960.46 (7.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.67%
Yearly Dividend4.25
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)5.16%
PT rev (3m)25.03%
EPS NQ rev (1m)0.25%
EPS NQ rev (3m)3.9%
EPS NY rev (1m)0.02%
EPS NY rev (3m)4.78%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)2.79%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)3.35%
Valuation
Industry RankSector Rank
PE 47.53
Fwd PE 31.86
P/S 16.63
P/FCF 153.51
P/OCF 61.51
P/B 41.53
P/tB 86.3
EV/EBITDA 36.08
EPS(TTM)18.73
EY2.1%
EPS(NY)27.95
Fwd EY3.14%
FCF(TTM)5.8
FCFY0.65%
OCF(TTM)14.47
OCFY1.63%
SpS53.54
BVpS21.44
TBVpS10.32
PEG (NY)0.56
PEG (5Y)2.87
Graham Number95.05
Profitability
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROCE 35.28%
ROIC 28.84%
ROICexc 33.25%
ROICexgc 41.06%
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
FCFM 10.83%
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexgc growth 3Y1.59%
ROICexgc growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.82%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Debt/EBITDA 1.44
Cap/Depr 507.66%
Cap/Sales 16.2%
Interest Coverage 250
Cash Conversion 56.78%
Profit Quality 34.96%
Current Ratio 1.55
Quick Ratio 1.24
Altman-Z 8.28
F-Score7
WACC9.31%
ROIC/WACC3.1
Cap/Depr(3y)385.26%
Cap/Depr(5y)286.02%
Cap/Sales(3y)16.93%
Cap/Sales(5y)13.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
EPS Next Y84.97%
EPS Next 2Y58.86%
EPS Next 3Y46.26%
EPS Next 5Y32.61%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
Revenue Next Year41.38%
Revenue Next 2Y31.06%
Revenue Next 3Y26.04%
Revenue Next 5Y19.64%
EBIT growth 1Y82.81%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year101.98%
EBIT Next 3Y46.72%
EBIT Next 5Y33.2%
FCF growth 1Y4003.21%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y158.46%
OCF growth 3Y6.69%
OCF growth 5Y12.76%

ELI LILLY & CO / 1LLY.MI FAQ

What is the fundamental rating for 1LLY stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1LLY.MI.


What is the valuation status of ELI LILLY & CO (1LLY.MI) stock?

ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (1LLY.MI). This can be considered as Overvalued.


Can you provide the profitability details for ELI LILLY & CO?

ELI LILLY & CO (1LLY.MI) has a profitability rating of 9 / 10.


What is the expected EPS growth for ELI LILLY & CO (1LLY.MI) stock?

The Earnings per Share (EPS) of ELI LILLY & CO (1LLY.MI) is expected to grow by 84.97% in the next year.


Is the dividend of ELI LILLY & CO sustainable?

The dividend rating of ELI LILLY & CO (1LLY.MI) is 4 / 10 and the dividend payout ratio is 28.28%.